Imaging of the Vulnerable Atherosclerotic Plaque. Pre-Clinical Evaluation of PET Tracers for Vascular Inflammation

Atherosclerosis is a vascular inflammatory disease causing coronary artery disease, myocardial infarct and stroke, the leading causes of death in Finland and in many other countries. The development of atherosclerotic plaques starts already in childhood and is an ongoing process throughout life. Rupture of a plaque and the following occlusion of the vessel is the main reason for myocardial infarct and stroke, but despite extensive research, the prediction of rupture remains a major clinical problem. Inflammation is considered a key factor in the vulnerability of plaques to rupture. Measuring the inflammation in plaques non-invasively is one potential approach for identification of vulnerable plaques. The aim of this study was to evaluate tracers for positron emission tomography (PET) imaging of vascular inflammation. The studies were performed with a mouse model of atherosclerosis by using ex vivo biodistribution, autoradiography and in vivo PET and computed tomography (CT). Several tracers for inflammation activity were tested and compared with the morphology of the plaques. Inflammation in the atherosclerotic plaques was evaluated as expression of active macrophages. Systematic analysis revealed that the uptake of 18F-FDG and 11C-choline, tracers for metabolic activity in inflammatory cells, was more prominent in the atherosclerotic plaques than in the surrounding healthy vessel wall. The tracer for αvβ3 integrin, 18Fgalacto- RGD, was also found to have high potential for imaging inflammation in the plaques. While 11C-PK11195, a tracer targeted to receptors in active macrophages, was shown to accumulate in active plaques, the target-to-background ratio was not found to be ideal for in vivo imaging purposes. In conclusion, tracers for the imaging of inflammation in atherosclerotic plaques can be tested in experimental pre-clinical settings to select potential imaging agents for further clinical testing. 18F-FDG, 18F-galacto-RGD and 11C-choline choline have good properties, and further studies to clarify their applicability for atherosclerosis imaging in humans are warranted.

18F-Labeled Presynaptic Dopaminergic Tracers. Synthesis, Radiochemical Analyses, and Preclinical Evaluation of [18F]FDOPA and [18F]CFT

Dysfunction of the dopaminergic system in brain is involved in several pathological conditions such as Parkinson’s disease and depression. 2β-Carbomethoxy-3β-(4-[18F] fluorophenyl)tropane ([18F]CFT) and 6-[18F]fluoro-L-dopa ([18F]FDOPA) are tracers for imaging the dopaminergic function with positron emission tomography (PET). Peripheral uptake of [18F]FDOPA is also used in the localization and diagnosis of neuroendocrine tumors. [18F]FDOPA and [18F]CFT can be synthesized by electrophilic fluorodestannylation. However, the specific radioactivity (SA) in the electrophilic fluorination is low with traditional synthetic methods. In this study, [18F]FDOPA and [18F]CFT were synthesized using post-target-produced [18F]F2 as an electrophilic fluorination agent. With this method, tracers are produced with sufficient SA for neuroreceptor studies. Specific aims in this study were to replace Freon-11 in the production of [18F]FDOPA due to the ozone depleting properties of this solvent, to determine pharmacological specificity and selectivity of [18F]CFT with respect to monoamine transporters, and to compare the ability of these tracers to reflect the degree of nigral neuronal loss in rats in which the dopaminergic system in the brain had been unilaterally destroyed by 6- OHDA. Post-target-produced [18F]F2 was successfully used in the production of [18F]FDOPA and [18F]CFT. The SA achieved was substantially higher than in previous synthetic methods. Deuterated compounds, CD2Cl2, CDCl3 and C3D6O, were found to be suitable solvents for replacing Freon-11. Both [18F]FDOPA and [18F]CFT demonstrated nigrostriatal dopaminergic hypofunction and correlated with the number of nigral dopaminergic neurons in the 6-OHDA lesioned rat. However, the dopamine transporter (DAT) tracer [18F]CFT was more sensitive than the dopamine synthesis tracer [18F]FDOPA in detecting these defects because of the higher non-specific uptake of [18F]FDOPA. [18F]CFT can also be used for imaging the norepinephrine transporter (NET) because of the specific uptake into the locus coeruleus. The observation that [18F]CFT exhibits specific uptake in the pancreas warrants further studies in humans with respect to potential utility in pancreatic imaging

PET Imaging of Osteomyelitis. Feasibility of 18F-FDG, 68Ga-Chloride and 68Ga-DOTAVAP-P1 Tracers in Staphylococcal Bone Infections

Due to technical restrictions of the database system the title of the thesis does not show corretly on this page. Numbers in the title are in superscript. Please see the PDF-file for correct title. ---- Osteomyelitis is a progressive inflammatory disease of bone and bone marrow that results in bone destruction due to an infective microorganism, most frequently Staphylococcus aureus. Orthopaedic concern relates to the need for reconstructive and trauma-related surgical procedures in the fast grow¬ing population of fragile, aged patients, who have an increased susceptibility to surgical site infections. Depending on the type of osteomyelitis, infection may be acute or a slowly progressing, low-grade infection. Peri-implant infections lead to implant loosening. The emerging antibiotic resistance of com¬mon pathogens further complicates the situation. With current imaging methods, significant limitations exist in the diagnosing of osteomyelitis and implant-related infections. Positron emission tomography (PET) with a glucose analogue, 18F-fluoro¬deoxyglucose (18F-FDG), seems to facilitate a more accurate diagnosis of chronic osteomyelitis. The method is based on the increased glucose consumption of activated inflammatory cells. Unfortunately, 18F-FDG accumulates also in sterile inflammation regions and causes false-positive findings, for exam¬ple, due to post-operative healing processes. Therefore, there is a clinical need for new, more infection-specific tracers. In addition, it is still unknown why 18F-FDG PET imaging is less accurate in the detec¬tion of periprosthetic joint infections, most frequently due to Staphylococcus epidermidis. This doctoral thesis focused on testing novel PET tracers (68Ga-chloride and 68Ga-DOTAVAP-P1) for early detections of bone infections and evaluated the role of pathogen-related factors in the appli¬cations of 18F-FDG PET in the diagnostics of bone infections. For preclinical models of S. epidermidis and S. aureus bone/implant infections, the significance of the causative pathogen was studied with respect to 18F-FDG uptake. In a retrospective analysis of patients with confirmed bone infections, the significance of the presence or absence of positive bacterial cultures on 18F-FDG uptake was evalu¬ated. 18F-FDG and 68Ga-chloride resulted in a similar uptake in S. aureus osteomyelitic bones. However, 68Ga-chloride did not show uptake in healing bones, and therefore it may be a more-specific tracer in the early post-operative or post-traumatic phase. 68Ga-DOTAVAP-P1, a novel synthetic peptide bind¬ing to vascular adhesion protein 1 (VAP-1), was able to detect the phase of inflammation in healing bones, but the uptake of the tracer was elevated also in osteomyelitis. Low-grade peri-implant infec¬tions due to S. epidermidis were characterized by a low uptake of 18F-FDG, which reflects the virulence of the causative pathogen and the degree of leukocyte infiltration. In the clinical study, no relationship was found between the level of 18F-FDG uptake and the presence of positive or negative bacterial cul¬tures. Thus 18F-FDG PET may help to confirm metabolically active infection process in patients with culture-negative, histologically confirmed, low-grade osteomyelitis.

New [18F]Tracers for Alzheimer's Disease Imaging. Labeling Synthesis And Biological Testing

Alzheimer’s disease (AD) is the most common form of dementia. Characteristic changes in an AD brain are the formation of β-amyloid protein (Aβ) plaques and neurofibrillary tangles, though other alterations in the brain have also been connected to AD. No cure is available for AD and it is one of the leading causes of death among the elderly in developed countries. Liposomes are biocompatible and biodegradable spherical phospholipid bilayer vesicles that can enclose various compounds. Several functional groups can be attached on the surface of liposomes in order to achieve long-circulating target-specific liposomes. Liposomes can be utilized as drug carriers and vehicles for imaging agents. Positron emission tomography (PET) is a non-invasive imaging method to study biological processes in living organisms. In this study using nucleophilic 18F-labeling synthesis, various synthesis approaches and leaving groups for novel PET imaging tracers have been developed to target AD pathology in the brain. The tracers were the thioflavin derivative [18F]flutemetamol, curcumin derivative [18F]treg-curcumin, and functionalized [18F]nanoliposomes, which all target Aβ in the AD brain. These tracers were evaluated using transgenic AD mouse models. In addition, 18F-labeling synthesis was developed for a tracer targeting the S1P3 receptor. The chosen 18F-fluorination strategy had an effect on the radiochemical yield and specific activity of the tracers. [18F]Treg-curcumin and functionalized [18F]nanoliposomes had low uptake in AD mouse brain, whereas [18F]flutemetamol exhibited the appropriate properties for preclinical Aβ-imaging. All of these tracers can be utilized in studies of the pathology and treatment of AD and related diseases.

Remote Observation of Radioactive Permit-Required Confined Spaces – Case: Posiva Oy’s Fuel Handling Cell

Posiva Oy’s final disposal facility’s encapsulation plant will start to operate in the 2020s. Once the operation starts, the facility is designed to run more than a hundred years. The encapsulation plant will be first of its kind in the world, being part of the solution to solve a global issue of final disposal of nuclear waste. In the encapsulation plant’s fuel handling cell the spent nuclear fuel will be processed to be deposited into the Finnish bedrock, into ONKALO. In the fuel handling cell, the environment is highly radioactive forming a permit-required enclosed space. Remote observation is needed in order to monitor the fuel handling process. The purpose of this thesis is to map (Part I) and compare (Part II) remote observation methods to observe Posiva Oy’s fuel handling cell’s process, and provide a possible theoretical solution for this case. Secondary purpose for this thesis is to provide resources for other remote observation cases, as well as to inform about possible future technology to enable readiness in the design of the encapsulation plant. The approach was to theoretically analyze the mapped remote observation methods. Firstly, the methods were filtered by three environmental challenges. These are the high levels of radiation, the permit-required confined space and the hundred year timespan. Secondly, the most promising methods were selected by the experts designing the facility. Thirdly, a customized feasibility analysis was created and performed on the selected methods to rank the methods with scores. The results are the mapped methods and the feasibility analysis scores. The three highest scoring methods were radiation tolerant camera, fiberscope and audio feed. A combination of these three methods was given as a possible theoretical solution for this case. As this case is first in the world, remote observation methods for it had not been thoroughly researched. The findings in this thesis will act as initial data for the design of the fuel handling cell’s remote observation systems and can potentially effect on the overall design of the facility by providing unique and case specific information. In addition, this thesis could provide resources for other remote observation cases.

Plasmapolttoprosessin kehittäminen ja optimointi

Ydinvoimaloidenprimaarivesikierron puhdistukseen käytetään ioninvaihtohartsia. Käytönjälkeen ioninvaihtohartsi luokitellaan matalaja keskiaktiivisiin jätteisiin. Plasmakäsittelyllä käytetyn ioninvaihtohartsin tilavuutta voidaan pienentää sekä sen orgaaninen luonne poistaa. Plasmakäsittelyn tarkoituksena on hapettaa orgaaninen aines oksideiksi, jotka poistuvat prosessista savukaasuina. Epäorgaaninen aines, joka sisältää radioaktiivisen aineksen, on tarkoitus hapettaa oksideiksi ja sulfideiksi, jotka voidaan kerätä talteen tuhkana. Tässä diplomityössä käsitellään käytetyn ioninvaihtohartsin käsittelyyn suunnitellun plasmapolttoprosessin kehittämistä ja optimointia. Ioninvaihtohartsin plasmakäsittelyssä syntyvien reaktiotuotteiden selvittäminen suoritettiin tarkastelemalla ainetaseita sekä aihetta käsitteleviä tutkimuksia. Näiden perusteella parannettiin jäähdytystä, suunniteltiin jatkuvatoiminen syöttömenetelmä sekä laadittiin toimintaalueen reunaehdot laitteistolle. Koelaitteistossa 6,5 kW:n rfteho syötetään sovitinpiirin ja kuparisen induktiokelan kautta plasmaan. Plasmakaasuna on käytetty hapenja argonin seoskaasua. Plasmapolttoa on seurattu massaspektrometrilla, optisella emissiospektrometrilla, lämpösekä painemittareilla. Laskennan ja kokeiden pohjalta selvitettiin optimaalinen seossuhde plasmakaasulle, paineen ja tehon noston vaikutus hartsin polttonopeuteen sekä jatkuvatoimisen syöttömenetelmän edut panostoimiseen syöttöön. Rfgeneraattorin teho rajoitti jatkuvatoimisen polttonopeuden 130 g/h ja hetkellisen polttonopeuden 175 g/h. Radioaktiivisten aineiden pidätys oli 93,5 % cesiumin osalta. Tulosten perusteella 4 kg/h ioninvaihtohartsia polttavan laitteiston tehon lähteeksi tarvitaan 65 kW rfgeneraattori. Palamattoman hartsin ja tuhkan kulkeutuminen partikkelisuodattimille sekä reaktiotuotteena syntyvien rikinoksidien käsittely vaatii vielä jatkotutkimusta.

Käytetyn ydinpolttoaineen kapselointilaitoksessa muodostuvat radioaktiiviset jätteet

Tässä työssä ontarkasteltu käytetyn ydinpolttoaineen kapselointilaitoksessa muodostuvia radioaktiivisia jätteitä. Kapselointilaitos rakennetaan Olkiluotoon joko Olkiluodon ydinvoimalaitoksen käytetyn ydinpolttoaineen välivaraston yhteyteen tai loppusijoituslaitokseen kytkettynä laitoksena. Työssä on otettu huomioon molemmat vaihtoehdot ja niiden eroavaisuudet prosessien ja jätemäärien osilta. Kaikki jäte, joka muodostuu kapselointilaitoksen valvonta-alueella, luokitellaan radioaktiiviseksi jätteeksi. Radioaktiivisia jätteitä muodostuu, kun käytetystä ydinpolttoaineesta irronneet radioaktiiviset aineet kontaminoivat laitoksen rakenteita ja laitteita. Muodostuvat radioaktiiviset jätteet kiinteytetään ja sijoitetaan loppusijoitustilan yhteyteen rakennettavaan käyttö- ja käytöstäpoisto-jäteluolaan. Hyvin vähäaktiivinen jäte voidaan vapauttaa valvonnasta aktiivisuusmittauksen jälkeen. Radioaktiivisia jätteitä muodostuu kapselointilaitoksen toiminnan aikana vähäisiä määriä verrattuna ydinvoimalaitoksiin. Vertailtaessa molempien kapselointilaitosvaihtoehtojen radioaktiivisten jätteiden määriä, ainoastaan loppusijoitettavan nestemäisten jätteiden määrässä on eroa.

Two-photon excitation fluorometry in detection of infectious diseases

Because of the heavily overlapping symptoms, pathogen-specific diagnosis and treatment of infectious diseases is difficult based on clinical symptoms alone. Therefore, patients are often treated empirically. More efficient treatment and management of infectious diseases would require rapid point-of-care compatible in vitro diagnostic methods. However, current point-of-care methods are unsatisfactory in performance and in cost structure. The lack of pointof- care methods results in unnecessary use of antibiotics, suboptimal use of virus-specific drugs, and compromised patient care. In this thesis, the applicability of a two-photon excitation fluorometry is evaluated as a tool for rapid detection of infectious diseases. New separation-free immunoassay methodologies were developed and validated for the following application areas: general inflammation markers, pathogen-specific antibodies, pathogen-specific antigens, and antimicrobial susceptibility testing. In addition, dry-reagent methodology and nanoparticulate tracers are introduced in context to the technique. The results show that the new assay technique is a versatile tool for rapid detection of infectious diseases in many different application areas. One particularly attractive area is rapid multianalyte testing of respiratory infections, where the technique was shown to allow simple assay protocols and comparable performance to the state-of-the-art laboratory methods. If implemented in clinical diagnostic use, the new methods could improve diagnostic testing routines, especially in rapid testing of respiratory tract infections.

Kontaminaatiomittaukset Loviisan voimalaitoksella

Kandidaatintyössä esitellään Loviisan ydinvoimalaitoksella käytössä olevia menetelmiä ja mittalaitteita radioaktiivisen kontaminaation havaitsemiseen ja mittaamiseen.

Genetic Factors in the Regulation of Striatal and Extrastriatal Dopamine D2 Receptor Expression

Positron emission tomography (PET) studies on healthy individuals have revealed a marked interindividual variability in striatal dopamine D2 receptor density that can be partly accounted for by genetic factors. The examination of the extrastriatal lowdensity D2 receptor populations has been impeded by the lack of suitable tracers. However, the quantification of these D2 receptor populations is now feasible with recently developed PET radioligands. The objective of this thesis was to study brain neurobiological correlates of common functional genetic variants residing in candidate genes relevant for D2 receptor functioning. For this purpose, healthy subjects were studied with PET imaging using [₁₁C]raclopride and [₁₁C]FLB457 as radioligands. The candidate genes examined in this work were the human D2 receptor gene (DRD2) and the catechol-Omethyltransferase gene (COMT). The region-specific genotypic influences were explored by comparing D2 receptor binding properties in the striatum, the cortex and the thalamus. As an additional study objective, the relationship between cortical D2 receptor density and a cognitive phenotype i.e. verbal memory and learning was assessed. The main finding of this study was that DRD2 C957T genotype altered markedly D2 receptor density in the cortex and the thalamus whereas in the striatum the C957T genotype affected D2 receptor affinity, but not density. Furthermore, the A1 allele of the DRD2-related TaqIA polymorphism showed increased cortical and thalamic D2 receptor density, but had the opposite effect on striatal D2 receptor density. The DRD2 –141C Ins/Del or the COMT Val158Met genotypes did not change D2 receptor binding properties. Finally, unlike previously reported, cortical D2 receptor density did not show any significant correlation with verbal memory function. The results of this study suggest that the C957T and the TaqIA genotypes have region-specific neurobiological correlates in brain dopamine D2 receptor availability in vivo. The biological mechanisms underlying these findings are unclear, but they may be related to the region-specific regulation of dopamine neurotranssion, gene/receptor expression and epigenesis. These findings contribute to the understanding of the genetic regulation of dopamine and D2 receptor-related brain functions in vivo in man. In addition, the results provide potentially useful endophenotypes for genetic research on psychiatric and neurological disorders.

Free Flap Monitoring. Using Tissue Oxygen Measurement and Positron Emission Tomography

Aims:This study was carried out to evaluate the feasibility of two different methods to determine free flap perfusion in cancer patients undergoing major reconstructive surgery. The hypotheses was that low perfusion in the flap is associated with flap complications. Patients and methods: Between August 2002 and June 2008 at the Department of Otorhinolaryngology – Head and Neck Surgery, Department of Surgery, and at the PET Centre, Turku, 30 consecutive patients with 32 free flaps were included in this study. The perfusion of the free microvascular flaps was assessed with positron emission tomography (PET) and radioactive water ([¹⁵O] H₂O) in 40 radiowater injections in 33 PET studies. Furthermore, 24 free flaps were monitored with a continuous tissue oxygen measurement using flexible polarographic catheters for an average of three postoperative days. Results: Of the 17 patients operated on for head and neck (HN) cancer and reconstructed with 18 free flaps, three re-operations were carried out due to poor tissue oxygenation as indicated by p_tiO₂ monitoring results and three other patients were reoperated on for postoperative hematomas in the operated area. Blood perfusion assessed with PET (BF_PET) was above 2.0 mL / min / 100 g in all flaps and a low flap-to-muscle BFPET ratio appeared to correlate with poor survival of the flap. Survival in this group of HN cancer patients was 9.0 months (median, range 2.4-34.2) after a median follow-up of 11.9 months (range 1.0-61.0 months). Seven HN patients of this group are alive without any sign of recurrence and one patient has died of other causes. All of the 13 breast reconstruction patients included in the study are alive and free of disease at a median follow-up time of 27.4 months (range 13.9-35.7 months). Re-explorations were carried out in three patients due data provided by p_tiO₂ monitoring and one re-exploration was avoided on the basis of adequate blood perfusion assessed with PET. Two patients had donorsite morbidity and 3 patients had partial flap necrosis or fat necrosis. There were no total flap losses. Conclusions: P_tiO₂ monitoring is a feasible method of free flap monitoring when flap temperature is monitored and maintained close to the core temperature. When other monitoring methods give controversial results or are unavailable, [₁₅O] H₂O PET technique is feasible in the evaluation of the perfusion of the newly reconstructed free flaps.

Imaging of Dopamine and Serotonin Transporters. Pre-clinical Studies with Radiotracers for Positron Emission Tomography

The action of the neurotransmitters dopamine (DA) and serotonin (5-HT) at synapses is terminated by their rapid reuptake into presynaptic nerve endings via plasma membrane dopamine (DAT) and serotonin (SERT) transporters. Alterations in the function of these transporters have been suggested as a feature of several neurological and neuropsychiatric diseases, such as Parkinson’s disease (PD), depression, and anxiety. A suitable clinical method for studying these transporters non-invasively in vivo is positron emission tomography (PET) utilizing radiopharmaceuticals (tracers) labelled with short-lived positron-emitting radionuclides. The aim of this study was to evaluate in rats two novel radiotracers, [¹⁸F]beta -CFT-FP and ¹⁸FFMe-McN, for imaging DAT and SERT, respectively, using in vitro, ex vivo and in vivo methods. Substituting an N-methyl in [¹⁸F]beta-CFT, a well known DAT tracer, with a ¹⁸Ffluoropropyl group significantly changed the properties of the tracer. [¹⁸F]beta- CFT showed slow kinetics and metabolism, and a high specific uptake in the striatum, whereas [¹⁸F]beta-CFT-FP showed fast kinetics and metabolism, and a moderate specific uptake in the striatum. [¹⁸F]betaCFT-FP was selective for DAT; but [¹⁸F]beta-CFT also bound to the noradrenaline transporter. [¹⁸F]beta-CFT-FP may be a suitable PET tracer for imaging the striatal DAT sites, but a tracer with a higher affinity is needed for imaging extrastriatal DAT sites. In rats, ¹⁸FFMe-McN showed high target-to-non-target ratios, specificity and selectivity for SERT, but slow kinetics. However, ¹⁸FFMe-McN reveals potential for imaging SERT, at least in pre-clinical studies. In addition, the sensitivities of [¹⁸F]beta CFT and [¹⁸ F]FDOPA (a precursor of DA) for detecting mild nigrostriatal hypofunction were compared in an animal model of PD. The uptake of [¹⁸F]FDOPA was significantly affected by compensatory effects in dopaminergic cells, whereas [¹⁸F]beta-CFT was more sensitive and therefore more suitable for PET studies of mild dopaminergic symptoms. In conclusion, both novel tracers, [¹⁸F]-CFT-FP and ¹⁸FFMe-McN, have potential, but are not optimal PET tracers for DAT and SERT imaging in rats, respectively. [¹⁸F]beta-CFT is superior to [18F]FDOPA for imaging mild nigral lesions in rat brains.

Loviisan ydinvoimalaitoksen todennäköisyyspohjaisen riskianalyysin tason 2 epävarmuustarkastelut

Diplomityössä tarkastellaan Loviisan ydinvoimalaitoksen todennäköisyyspohjaisen riskianalyysin tason 2 epävarmuuksia. Tason 2 riskitutkimuksissa tutkitaan ydinvoimalaitosonnettomuuksia, joiden seurauksena osa reaktorin radioaktiivisista aineista vapautuu ympäristöön. Näiden tutkimuksien päätulos on suuren päästön vuotuinen taajuus ja se on pääosin todelliseen laitoshistoriaan perustuva tilastollinen odotusarvo. Tämän odotusarvon uskottavuutta voidaan parantaa huomioimalla merkittävimmät laskentaan liittyvät epävarmuudet. Epävarmuuksia laskentaan aiheutuu muiden muassa vakavan reaktorionnettomuuden ilmiöistä, turvallisuusjärjestelmien laitteista, inhimillisistä toiminnoista sekä luotettavuusmallin määrittelemättömistä osista. Diplomityössä kuvataan, kuinka epävarmuustarkastelut integroidaan osaksi Loviisan ydinvoimalaitoksen todennäköisyyspohjaisia riskianalyysejä. Tämä toteutetaan diplomityössä kehitetyillä apuohjelmilla PRALA:lla ja PRATU:lla, joiden avulla voidaan lisätä laitoshistorian perusteella muodostetut epävarmuusparametrit osaksi riskianalyysien luotettavuusdataa. Lisäksi diplomityössä on laskettu laskentaesimerkkinä Loviisan ydinvoimalaitoksen suuren päästön vuotuisen taajuuden vaihtelua kuvaava luottamusväli. Tämä laskentaesimerkki pohjautuu pääosin konservatiivisiin epävarmuusarvioihin, ei todellisiin tilastollisiin epävarmuuksiin. Laskentaesimerkin tulosten perusteella Loviisan suuren päästön taajuudella on laaja vaihteluväli; virhekertoimeksi saatiin 8,4 nykyisillä epävarmuusparametreilla. Suuren päästön taajuuden luottamusväliä voidaan kuitenkin tulevaisuudessa supistaa, kun hyödynnetään todelliseen laitoshistoriaan perustuvia epävarmuusparametreja.

Kehittyneiden ydinpolttoainekiertojen ympäristövaikutusten ja taloudellisuuden arviointia

Kaikkein yleisin käytössä oleva ydinpolttoainekierto on nykyisin avoin, jossa käytetty ydinpolttoaine loppusijoitetaan suoraan ilman jälleenkäsittelyä. Nykyisin kehitteillä olevat uuden sukupolven ydinreaktorit ovat kuitenkin pääosin suunniteltu osittain tai kokonaan suljetuille ydinpolttoainekierroille, jossa käytetty polttoaine jälleenkäsitellään ja osa materiaaleista kierrätetään. Tämän työn tavoitteena oli arvioida näitä kehittyneitä ydinpolttoainekiertoja ympäristövaikutusten ja taloudellisuuden suhteen. Työn yleisluonteista vertailua varten valittiin neljä erilaista kehittynyttä polttoainekiertoskenaariota, joita verrattiin avoimeen polttoainekiertoon erilaisten parametrien avulla. Parametreinä käytettiin muun muassa uraanin kulutusta, loppusijoitettavan jätteen määrää, aktiivisuutta ja lämmöntuottoa sekä käytönaikaisten radioaktiivisten päästöjen määrää. Yleislounteisen arvioinnin lisäksi työssä tarkasteltiin polttoainekiertoa myös Suomen näkökulmasta. Nykyistä polttoainekiertoa verrattiin kahteen erilaiseen tulevaisuuden versioon. Kestävän kehityksen osalta kehittyneet polttoainekierrot vähensivät ympäristövaikutusten määrää avoimeen polttoainekiertoon verrattuna. Kehittyneiden polttoainekiertojen kustannukset olivat avoimen polttoainekierron kustannuksia suuremmat. Kokonaiskustannuksissa ero oli kaikilla vertailuskenaarioilla alle 20 %, mutta polttoainekiertokustannuksissa kustannusten kasvu oli välillä 27-45 % riippuen skenaariosta. Suomen tapauksessa tulokset olivat hyvin samankaltaisia. Uraanin kulutus ja loppusijoitettavan jätteen määrä väheni kehittyneempien polttoainekiertojen johdosta. Polttoainekiertokustannukset nousivat noin puolitoistakertaisiksi, mutta vaikutus kokonaiskustannuksiin oli vain noin 10 %. Johtopäätöksenä voidaan todeta, ettäydinpolttoainekierron ympäristövaikutuksia on mahdollista vähentää osittain tai kokonaan suljettujen polttoainekiertojen avulla. Vaikka polttoainekierron kustannukset kasvavat, niiden vaikutus ydinsähkön kokonaiskustannuksiin ei ole niin merkittävä.